Auriga Reiterates a 'Buy' Rating on Thoratec Corp. (THOR); Strong Pivotal Data Should Lead to DT Approval
Tweet Send to a Friend
Auriga reiterates a 'Buy' rating on Thoratec Corp. (Nasdaq: THOR), price target $40.
Auriga analyst says, "We consider 58% two-year ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Auriga analyst says, "We consider 58% two-year ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
